Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-137 |
Sentence |
denotes |
Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells. |
T1 |
0-137 |
Sentence |
denotes |
Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells. |
TextSentencer_T2 |
138-281 |
Sentence |
denotes |
Multiple myeloma (MM) is an incurable plasma cell malignancy with a terminal phase marked by increased proliferation and resistance to therapy. |
T2 |
138-281 |
Sentence |
denotes |
Multiple myeloma (MM) is an incurable plasma cell malignancy with a terminal phase marked by increased proliferation and resistance to therapy. |
TextSentencer_T3 |
282-439 |
Sentence |
denotes |
Arsenic trioxide (ATO), an antitumor agent with a multifaceted mechanism of action, displayed clinical activity in patients with late-stage multiple myeloma. |
T3 |
282-439 |
Sentence |
denotes |
Arsenic trioxide (ATO), an antitumor agent with a multifaceted mechanism of action, displayed clinical activity in patients with late-stage multiple myeloma. |
TextSentencer_T4 |
440-526 |
Sentence |
denotes |
However, the precise mechanism(s) of action of ATO has not been completely elucidated. |
T4 |
440-526 |
Sentence |
denotes |
However, the precise mechanism(s) of action of ATO has not been completely elucidated. |
TextSentencer_T5 |
527-727 |
Sentence |
denotes |
In the present study, we used proteomics to analyze the ATO-induced protein alterations in MM cell line U266 and then investigated the molecular pathways responsible for the anticancer actions of ATO. |
T5 |
527-727 |
Sentence |
denotes |
In the present study, we used proteomics to analyze the ATO-induced protein alterations in MM cell line U266 and then investigated the molecular pathways responsible for the anticancer actions of ATO. |
TextSentencer_T6 |
728-964 |
Sentence |
denotes |
Several clusters of proteins altered in expression in U266 cells upon ATO treatment were identified, including down-regulated signal transduction proteins and ubiquitin/proteasome members, and up-regulated immunity and defense proteins. |
T6 |
728-964 |
Sentence |
denotes |
Several clusters of proteins altered in expression in U266 cells upon ATO treatment were identified, including down-regulated signal transduction proteins and ubiquitin/proteasome members, and up-regulated immunity and defense proteins. |
TextSentencer_T7 |
965-1076 |
Sentence |
denotes |
Significantly regulated 14-3-3zeta and heat shock proteins (HSPs) were selected for further functional studies. |
T7 |
965-1076 |
Sentence |
denotes |
Significantly regulated 14-3-3zeta and heat shock proteins (HSPs) were selected for further functional studies. |
TextSentencer_T8 |
1077-1274 |
Sentence |
denotes |
Overexpression of 14-3-3zeta in MM cells attenuated ATO-induced cell death, whereas RNAi-based 14-3-3zeta knock-down or the inhibition of HSP90 enhanced tumor cell sensitivity to the ATO induction. |
T8 |
1077-1274 |
Sentence |
denotes |
Overexpression of 14-3-3zeta in MM cells attenuated ATO-induced cell death, whereas RNAi-based 14-3-3zeta knock-down or the inhibition of HSP90 enhanced tumor cell sensitivity to the ATO induction. |
TextSentencer_T9 |
1275-1480 |
Sentence |
denotes |
These observations implicate 14-3-3zeta and HSP90 as potential molecular targets for drug intervention of multiple myeloma and thus improve our understanding on the mechanisms of antitumor activity of ATO. |
T9 |
1275-1480 |
Sentence |
denotes |
These observations implicate 14-3-3zeta and HSP90 as potential molecular targets for drug intervention of multiple myeloma and thus improve our understanding on the mechanisms of antitumor activity of ATO. |